Skip to main content
Year archive

Ascelia Pharma — 2020 filings

All 44 regulatory filings released by Ascelia Pharma (ACE) in 2020, sourced directly from the official regulator.

44 Filings
2020 Period
2020 filings (44)
Filing Released Lang
Ascelia Pharma gets US patent for second generation Mangoral
Regulatory Filings
2020-12-15 English
Ascelia Pharma får amerikanskt patent för andra generationens Mangoral
Regulatory Filings
2020-12-15 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-12-04 English
Ny studie visar att Mangorals visualisering av lesioner är lika effektiv som gadoliniumbaserat kontrastmedel
Regulatory Filings
2020-12-02 Swedish
New study shows Mangoral’s lesion visualization as effective as gadolinium contrast agent
Regulatory Filings
2020-12-02 English
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-05 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-05 English
Det uppskattade värdet på Mangorals marknadspotential höjs till 500-600 miljoner USD per år
Regulatory Filings
2020-10-21 Swedish
Upgraded estimate of addressable market for Mangoral to $500-600 million annually
Earnings Release FY 2020
2020-10-21 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-10-19 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H2 2020
2020-08-20 English
Change in number of shares and votes in Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2020-07-31 English
Ändring av antalet aktier och röster i Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2020-07-31 Swedish
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-02 English
Ascelia Pharma genomför en riktad nyemission om 4 697 781 aktier och tillförs cirka 98,7 MSEK
Share Issue/Capital Change
2020-06-30 Swedish
Ascelia Pharma completes a directed new share issue of 4,697,781 shares, raising approximately SEK 98.7 million
Capital/Financing Update
2020-06-30 English
Updated SPARKLE timelines due to Covid-19 impact
Regulatory Filings
2020-05-20 English
Uppdaterad tidsplan för SPARKLE till följd av Covid-19
Report Publication Announcement
2020-05-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-13 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-13 English
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 6 May 2020
AGM Information
2020-05-06 English
Kommuniké från årsstämma den 6 maj 2020 i Ascelia Pharma AB
AGM Information
2020-05-06 Swedish
Första deltagaren rekryterad till den kliniska studien med Mangoral för nedsatt leverfunktion
Regulatory Filings
2020-05-06 Swedish
First participant enrolled in the clinical hepatic impairment study with Mangoral
Regulatory Filings
2020-05-06 English
Patent för Oncoral godkänt i Japan
Regulatory Filings
2020-04-16 Swedish
Patent for Oncoral approved in Japan
Legal Proceedings Report
2020-04-16 English
Annual Report 2019
Annual Report FY 2019
2020-04-06 Swedish
Annual Report 2019
Annual Report FY 2019
2020-04-06 English
KALLELSE TILL ÅRSSTÄMMA I ASCELIA PHARMA AB
AGM Information
2020-04-03 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
AGM Information
2020-04-03 English
Correction to press release regarding in change in number of shares and votes in Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2020-04-01 English
Korrektion till pressmeddelande om ändring av antalet aktier och röster i Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2020-04-01 Swedish
Ändring av antalet aktier och röster i Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2020-03-31 Swedish
Change in number of shares and votes in Ascelia Pharma AB
Declaration of Voting Results & Voting Rights Announcements
2020-03-31 English
Nyemission och återköp av C-aktier för aktiesparprogram
Share Issue/Capital Change
2020-03-02 Swedish
Issue and repurchase of series C shares for share saving program
Share Issue/Capital Change
2020-03-02 English
First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral
Legal Proceedings Report
2020-02-19 English
Första patienten rekryterad till den registreringsgrundande kliniska fas III-studien SPARKLE med ledande läkemedelskandidaten Mangoral
Regulatory Filings
2020-02-19 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2020-02-14 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2020-02-14 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-01-27 English
Five sites now opened in the pivotal Phase III clinical study SPARKLE for lead drug candidate Mangoral
Regulatory Filings
2020-01-13 English
Fem kliniker är nu öppnade till den registreringsgrundande kliniska fas III-studien SPARKLE med ledande läkemedelskandidaten Mangoral
Regulatory Filings
2020-01-13 Swedish